AstraZeneca's "breast cancer ADC miracle drug" DS-8201 entered the new version of medical insurance directory
lgh9701
发表于 7 일전
3687
0
0
[AstraZeneca's "breast cancer ADC miracle drug" DS-8201 entered the new version of the medical insurance directory] According to the 2024 national medical insurance directory released today, the reporter found that the "breast cancer miracle drug" DS8201 Detriazumab for injection, which AstraZeneca was responsible for negotiations, appeared on the list of the directory. Previously, the drug failed to enter the 2023 medical insurance catalog after being included in the formal review list in 2023.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- JD realizes online medical insurance payment for purchasing drugs
- JD has connected to 353 pharmacies for high-density coverage of "online medication purchase medical insurance individual account payment" services throughout Beijing
- JD's "Online Drug Purchase and Medical Insurance Personal Account Payment" has been integrated into over 410 pharmacies in Beijing
- It is reported that the new version of Amazon Alexa will be mainly supported by Anthropic's AI model
- Technology Weekly | WeChat updates version on Apple iOS system; Taobao clarifies that merchants will gradually open WeChat Pay after September 12th
- AstraZeneca breast cancer treatment trial failed to meet expectations
- BeiGene: Several new indications for commercial products have been included in the 2024 National Medical Insurance Drug Catalog
- Novo Nordisk's world's first weekly insulin preparation, Novo Nordisk, has been included in the national medical insurance catalog
- AbbVie: Two new indications for Ruifu (Upatinib Extended Release Tablets) have been added to the national medical insurance catalog in China
- Top 20 US stock transactions: Eli Lilly rises over 4%, Biden administration plans to include weight loss drugs in healthcare and subsidy programs
-
"대적전 창시자 장충모: 인텔이 AI 물결을 따라잡지 못한 삼성의 문제는 경영전략에 있지 않다"12월 9일, 대적전 창시자 장충모의 자서전 전집의 신간 발표회가 중국 대만에서 개최되였다.행사장에서 경쟁사인 인텔 ...- 西西里柠檬2017
- 그저께 14:46
- Up
- Down
- Reply
- Favorite
-
12월 11일 CNN에 따르면 엘론 머스크의 순자산은 4000억 달러에 달해 사상 처음으로 이 관문을 돌파했다. 머스크의 재산은 그의 우주 탐사 기술 회사와 관련이 있는 200억 달러 가까이 다시 늘어난 것으로 알려졌다 ...- 真不是我干的的
- 9 시간전
- Up
- Down
- Reply
- Favorite
-
미국 동부 시간으로 월요일, 미국 주식 3대 지수는 집단적으로 하락하여 마감 마감되었는데, 나지는 0.62%, S & P500 지수는 0.61%, 지수는 0.54% 하락했다. 나스닥 중국 진룽지수는 8.54% 상승해 인기 있는 중국계 ...- 强绝商爸摇
- 그저께 13:58
- Up
- Down
- Reply
- Favorite
-
샤오펑자동차 웨이보 12월 11일 소식에 따르면 샤오펑 P7 + 는 출시 4주 만에 10000대의 샤오펑 P7 + 를 정식 인도했다.- 崔炫俊献
- 어제 12:18
- Up
- Down
- Reply
- Favorite
